Literature DB >> 18989399

Preparing T cell growth factor from rat splenocytes.

Christine Beeton1, K George Chandy.   

Abstract

Maintenance of antigen-specific T cell lines or clones in culture requires rounds of antigen-induced activation separated by phases of cell expansion. Addition of interleukin 2 to the culture media during the expansion phase is necessary to prevent cell death and sufficient to maintain short-term T cell lines but has been shown to increase Th1 polarization (3). Replacement of interleukin 2 by T cell growth factor (TCGF) which contains a mix of cytokines is more effective than interleukin 2 in maintaining long-term T cell lines in vitro (3). Moreover, TCGF can easily be prepared in large amounts in the laboratory and is much cheaper than recombinant interleukin 2. Here, we show how to prepare TCGF from rat splenocyte culture supernatants. For this procedure, we harvest spleens from naive Lewis rats euthanized for thymus and blood collection. We prepare single-cell suspensions from the spleens, lyze the red blood cells by osmotic shock, and seed the splenocytes in culture medium. The cells are stimulated with concanavalin A, a mitogen that non-selectively activates all rat T lymphocytes, inducing the production of cytokines. The culture supernantant is collected 48 hours later and excess concanavalin A is bound to alpha methyl mannoside to prevent it from activating T cell lines to which TCGF will be added. The TCGF is then sterile-filtered, aliquoted, and stored at -20 degrees C.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18989399      PMCID: PMC2557076          DOI: 10.3791/402

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

1.  Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.

Authors:  C Beeton; H Wulff; J Barbaria; O Clot-Faybesse; M Pennington; D Bernard; M D Cahalan; K G Chandy; E Béraud
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Propagation of lewis rat encephalitogenic T cell lines: T-cell-growth-factor is superior to recombinant IL-2.

Authors:  Felix Mor; Irun R Cohen
Journal:  J Neuroimmunol       Date:  2002-02       Impact factor: 3.478

3.  Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.

Authors:  C Beeton; J Barbaria; P Giraud; J Devaux; A M Benoliel; M Gola; J M Sabatier; D Bernard; M Crest; E Béraud
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

  3 in total
  11 in total

1.  Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.

Authors:  Frank Thiele; Sha Tao; Yi Zhang; Andreas Muschaweckh; Tina Zollmann; Ulrike Protzer; Rubert Abele; Ingo Drexler
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

2.  Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.

Authors:  Mark R Tanner; Rajeev B Tajhya; Redwan Huq; Elizabeth J Gehrmann; Kathia E Rodarte; Mustafa A Atik; Raymond S Norton; Michael W Pennington; Christine Beeton
Journal:  Clin Immunol       Date:  2017-04-04       Impact factor: 3.969

3.  Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury.

Authors:  Ryan D Fortune; Raymond J Grill; Christine Beeton; Mark Tanner; Redwan Huq; David S Loose
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

4.  The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1.

Authors:  Mohammad A Samie; Christian Grimm; Jeffrey A Evans; Cyntia Curcio-Morelli; Stefan Heller; Susan A Slaugenhaupt; Math P Cuajungco
Journal:  Pflugers Arch       Date:  2009-11       Impact factor: 3.657

5.  A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases.

Authors:  M Harunur Rashid; Redwan Huq; Mark R Tanner; Sandeep Chhabra; Keith K Khoo; Rosendo Estrada; Vikas Dhawan; Satendra Chauhan; Michael W Pennington; Christine Beeton; Serdar Kuyucak; Raymond S Norton
Journal:  Sci Rep       Date:  2014-03-28       Impact factor: 4.379

6.  Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis.

Authors:  Andreas Digre; Kailash Singh; Magnus Åbrink; Rogier M Reijmers; Stellan Sandler; Israel Vlodavsky; Jin-Ping Li
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

7.  Recurrent tissue-specific mtDNA mutations are common in humans.

Authors:  David C Samuels; Chun Li; Bingshan Li; Zhuo Song; Eric Torstenson; Hayley Boyd Clay; Antonis Rokas; Tricia A Thornton-Wells; Jason H Moore; Tia M Hughes; Robert D Hoffman; Jonathan L Haines; Deborah G Murdock; Douglas P Mortlock; Scott M Williams
Journal:  PLoS Genet       Date:  2013-11-07       Impact factor: 5.917

8.  Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.

Authors:  Redwan Huq; Errol L G Samuel; William K A Sikkema; Lizanne G Nilewski; Thomas Lee; Mark R Tanner; Fatima S Khan; Paul C Porter; Rajeev B Tajhya; Rutvik S Patel; Taeko Inoue; Robia G Pautler; David B Corry; James M Tour; Christine Beeton
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

9.  Canine adipose tissue-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating T cells in rats.

Authors:  Hyun-Wook Kim; Woo-Jin Song; Qiang Li; Sei-Myoung Han; Kee-Ok Jeon; Sang-Chul Park; Min-Ok Ryu; Hyung-Kyu Chae; Kweon Kyeong; Hwa-Young Youn
Journal:  J Vet Sci       Date:  2016-12-30       Impact factor: 1.672

10.  Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions.

Authors:  Cornelia Barnowski; Gregor Ciupka; Ronny Tao; Lei Jin; Dirk H Busch; Sha Tao; Ingo Drexler
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.